AHR Antagonist 5(Cat No.:I015472)is a small-molecule inhibitor designed to block the activity of the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor involved in xenobiotic metabolism, immune regulation, and cancer progression. By antagonizing AHR, it prevents receptor-mediated gene expression, including cytochrome P450 enzymes, and modulates downstream signaling linked to tumor growth, inflammation, and immune suppression. AHR Antagonist 5 is primarily used in cancer biology, immunology, and toxicology research, providing a valuable tool to dissect AHR-dependent pathways and evaluate its therapeutic potential in disease intervention strategies.